Aplex Bio AB

ABActive

Org 5592482870Nobels Väg 16, 171 65 SolnaResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2020 · 6 years old10-19 employees

Overview Financials People & ownership Related companies

Aplex Bio AB is a Swedish AB based in Solna, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2020, the company reported revenue of SEK 1,3M in its latest annual filing.

Revenue 2024

SEK 1,3M

-22% vs 2023

EBITDA margin

-141.3%

-115% vs 2023

Net profit 2024

SEK -1,8M

-115% vs 2023

Key ratios

See full ratios →

94.8%

This company

20202024

8.9×

This company

20202024

-5.9%

This company

20202024

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 1,3M	-22%
EBITDA	SEK -1,8M	-115%
Net profit	SEK -1,8M	-115%
Total assets	SEK 30,3M	+46%
Equity	SEK 28,7M	+44%
Employees	—	—

Contact

Address

Nobels Väg 16, 171 65 Solna

umear@aplex.bio

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Aplex Bio AB?

Aplex Bio AB is registered with Bolagsverket / SCB under Org 5592482870.

What is the revenue of Aplex Bio AB?

Aplex Bio AB reported revenue of SEK 1,3M in 2024.

Who is the CEO of Aplex Bio AB?

Umear Naseem is the CEO of Aplex Bio AB, in role since 2021.

Who is the chairman of Aplex Bio AB?

Lars Erik Jonas Wallberg chairs the board of Aplex Bio AB, in role since 2021.

Where is Aplex Bio AB headquartered?

Aplex Bio AB's registered address is Nobels Väg 16.

Aplex Bio AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Aplex Bio AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Aplex Bio AB